Abbott Unveils FreeStyle Libre 3 Plus: World’s Smallest CGM Sensor with Future AID Compatibility

What You Should Know: 

– At the American Diabetes Association conference, Abbott unveiled a new addition to its FreeStyle Libre portfolio – the FreeStyle Libre 3 Plus sensor

– The sensor boasts the distinction of being the world’s smallest, thinnest, and most discreet continuous glucose monitoring (CGM) sensor available.

Unmatched Design and Performance

The FreeStyle Libre 3 Plus sensor offers a unique combination of user-centric features:

  • Unmatched Discreetness: The sensor maintains the same size as the original Libre 3 sensor, making it about the size of two stacked pennies. This ensures exceptional comfort and discreet wear for users.
  • Extended Wear Time: The sensor offers a wear time of 15 days, eliminating the need for frequent replacements.
  • Future-Proof Technology: The Libre 3 Plus is designed for future compatibility with automated insulin delivery (AID) systems, empowering seamless integration with advanced diabetes management solutions as they become available.

Improved User Experience

The sensor streamlines glucose monitoring for users:

  • No Scanning Required: Gone are the days of finger pricking or scanning. When paired with the FreeStyle Libre 3 app or reader, the sensor automatically transmits glucose data to the smartphone, providing real-time readings with no additional action required.
  • Real-Time Glucose Data: The sensor measures glucose levels every minute and transmits updates to the app at the same frequency, offering a complete picture of glucose trends.

Availability

The FreeStyle Libre 3 Plus sensor will be available in the coming months at U.S. retail pharmacies and participating durable medical equipment (DME) suppliers.